Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
Gray, Glenda E, Dr, Allen, Mary, MS, Moodie, Zoe, PhD, Churchyard, Gavin, PhD, Bekker, Linda-Gail, PhD, Nchabeleng, Maphoshane, MBChB, Mlisana, Koleka, MBChB, Metch, Barbara, MS, de Bruyn, Guy, MBBCH, Latka, Mary H, PhD, Roux, Surita, MBChB, Mathebula, Matsontso, MBChB, Naicker, Nivashnee, MBChB, Ducar, Constance, PhD, Carter, Donald K, PhD, Puren, Adrien, MBBCH, Eaton, Niles, BA, McElrath, M Julie, MD, Robertson, Michael, MD, Corey, Lawrence, MD, Kublin, James G, MD
Published in The Lancet infectious diseases (01.07.2011)
Published in The Lancet infectious diseases (01.07.2011)
Get full text
Journal Article
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Gray, Glenda E, Prof, Moodie, Zoe, PhD, Metch, Barbara, MS, Gilbert, Peter B, PhD, Bekker, Linda-Gail, Prof, Churchyard, Gavin, PhD, Nchabeleng, Maphoshane, MBChB, Mlisana, Koleka, MBChB, Laher, Fatima, MBBCH, Roux, Surita, MBChB, Mngadi, Kathryn, MPhil, Innes, Craig, MBChB, Mathebula, Matsontso, MBChB, Allen, Mary, MS, McElrath, M Julie, Prof, Robertson, Michael, MD, Kublin, James, MD, Corey, Lawrence, Prof
Published in The Lancet infectious diseases (01.05.2014)
Published in The Lancet infectious diseases (01.05.2014)
Get full text
Journal Article